Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now full pipeline small index

Infertility, Male: full-pipeline trial registry

5 of 9 indexed Infertility, Male trials are currently recruiting.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 5 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Infertility, Male: 9 US clinical trials tracked, 5 recruiting.

Infertility, Male is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Pittsburgh, running 2 of these trials.

Enrollment posture brief

Registry condition infertility-male

OPEN 5 | RECR 56% | LATE 1 | EARLY 1 | RANK #1916 | SPON 2

Nearest open-share peer: Advanced Colorectal Cancer (56% recruiting · 9 trials)

Infertility, Male (this)56%Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Infertility, Male

Infertility, Male lists 5 open slots (56% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Infertility, Male on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Infertility, Male is recruiting above its size-band peers.

    5 of 9 indexed trials (55.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Infertility, Male research.

    University of Pittsburgh accounts for 2 of 9 trials (22.2%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Typical Infertility, Male enrolment sits around 90 participants.

    Median target enrolment is 90 among the 9 trials that report a genuine target (sentinel values excluded). 5 of those (55.6%) plan for fewer than 100 participants.

  4. Infertility, Male research is mostly interventional.

    7 interventional and 2 observational studies make up this index (77.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 31

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 1

Named interventions

Most-linked intervention names on Infertility, Male records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

FP Decision Tool and Discussion Behavioral
1 trials
in vitro fertilization Procedure
1 trials
Microfluidic Sperm Sorting Device
1 trials
Ultrasound-guided rete testis flushing and aspiration Procedure
1 trials
Spermatogonial Stem Cell Transplant and Testicular Tissue Grafting Procedure
1 trials
Power Prenatal for Sperm Dietary supplement
1 trials
Half ROSI-half Sperm Donor Fertilization Other
1 trials
Round Spermatid Injection (ROSI) Other
1 trials

US sites by state

Facility locations filed on Infertility, Male trials. A trial with sites in several states counts in each.

California 4 trials
Pennsylvania 2 trials
Ohio 1 trials
North Carolina 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Infertility, Male page

9 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Infertility, Male condition card totals 9 registered trials; most-linked intervention FP Decision Tool and Discussion; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.